Latest Innovation News

Vital Metals has raised A$6.8 million through a strategic placement led by US-based Strategic Resources LLC to advance its Tardiff Rare Earth project in Canada, aiming to deploy innovative Dry Field Force Extraction technology that could reshape project economics and environmental impact.

Locksley Resources has partnered with Rice University to pioneer domestic antimony processing in the US, aiming to reduce reliance on foreign supply and support critical defense and energy sectors.

InhaleRx Limited reported a widening half-year loss as it accelerates clinical trials for inhaled drug-device therapies, supported by a substantial $38.5 million funding facility.

Otto Energy has appointed industry veteran Chris Dorros as CEO, signaling a strategic push to leverage his two decades of upstream energy expertise. The move aligns with Otto’s growth ambitions and shareholder value focus.

EVT Group has released an extensive valuation update on its diversified $2.3 billion property portfolio, spotlighting landmark Sydney CBD assets alongside a broad hospitality and entertainment footprint across Australia, New Zealand, and Germany.

Regal Partners Limited reported robust half-year results for 1H25, with funds under management reaching $17.7 billion and normalised net profit after tax hitting $44.8 million. The firm achieved record net inflows and maintained a strong balance sheet, signaling continued growth momentum.

Renascor Resources has completed key preparatory milestones for its Purified Spherical Graphite demonstration plant in Adelaide, with construction set to begin next month. The facility aims to challenge China’s dominance in battery anode materials using an innovative, eco-friendly purification process.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

GDI Property Group has reported a strong turnaround in FY25, posting a $35.6 million net profit and a 20% increase in Funds From Operations, while maintaining its distribution at 5 cents per security.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Michael Hill International reported steady FY25 results with flat revenue and modest profit improvement amid challenging market conditions. The company is focusing on brand repositioning, operational efficiency, and AI innovation as it navigates a complex retail environment.

Michael Hill International reported broadly flat FY25 financial results despite challenging retail conditions, with growth in Australia and Canada offset by ongoing difficulties in New Zealand. Strategic initiatives and early FY26 sales hint at cautious optimism.